PodParley PodParley
PodParley
Teaser: Behandlung des mRCC: Duale Immuntherapie ONKO oder TKI-Kombination? episode artwork

EPISODE · Feb 29, 2024 · 1 MIN

Teaser: Behandlung des mRCC: Duale Immuntherapie ONKO oder TKI-Kombination?

from OnkoImpuls · host DIGIMED Verlag GmbH

Dialog zum ASCO-GU 2024 und neuen Studiendaten zum mRCC mit Frau Dr. Marit Ahrens von der Medizinischen Klinik II der Uniklinik Frankfurt und Frau Dr. Stefanie Zschäbitz, kommissarische Sektionsleiterin der Translationalen Uroonkologie am Universitätsklinikum Heidelberg. Die Expertinnen besprechen die Therapie des fortgeschrittenen Nierenzellkarzinoms sowie neue Studiendaten des ASCO-GU 2024. Ganze Folge hörbar unter: https://www.krebsgesellschaft.de/onko-internetportal/kongresse/asco-gu/asco-gu-2024-neues-zum-mrcc.html 

Episode metadata supplied by the publisher feed · Published Feb 29, 2024

Embed this episode

NOW PLAYING

Teaser: Behandlung des mRCC: Duale Immuntherapie ONKO oder TKI-Kombination?

0:00 1:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OnkoImpuls?

This episode is 1 minute long.

When was this OnkoImpuls episode published?

This episode was published on February 29, 2024.

Can I download this OnkoImpuls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!